Other

Workshop 05 - (INTERACTIVE) NCI/ASTRO Diversity Symposium: Increasing Minority Enrollment in Clinical Trials in Radiation Oncology: Why and How

Strategies to Improve Minority Clinical Trial Accrual in Radiation Oncology

Tuesday, October 23
1:45 PM - 2:00 PM
Location: Room 302

Mack Roach, MD, FASTRO

Disclosure:
Employment
National Cancer Institute: Board Member: Employee; University of California San Francisco: Professor, Depart of Radiation Oncology: Employee

Compensation
Bayer: Advisory Board, Travel Expenses; Blue Earth: Advisory Board, Honoraria, Travel Expenses; Ferring Pharma: Consultant, Honoraria, Travel Expenses; International Atomic Energy Agency: Consultant, Travel Expenses; Janssen Pharma: Advisory Board, Consultant, Travel Expenses; Myriad: Advisory Board, Honoraria, Travel Expenses; Tolmar: Advisory Board, Travel Expenses

Ownership
Abbott, Agilent, Altria, GSK, Hospira: Stock

Leadership
NCAB: Board Member

Presentation(s):

Send Email for Mack Roach


Assets

Strategies to Improve Minority Clinical Trial Accrual in Radiation Oncology



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Strategies to Improve Minority Clinical Trial Accrual in Radiation Oncology